Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ștefan AE"'
Publikováno v:
Journal of Genetic Engineering and Biotechnology, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background About one-third of patients with estrogen receptor alpha (ERα)-positive breast cancer have tumors which are progesterone receptor (PR) negative. PR is an important prognostic factor in breast cancer. Patients with ERα-positive/P
Externí odkaz:
https://doaj.org/article/6e39a48d35504bc79ba51ef2d9ae9919
Publikováno v:
Physics, Vol 4, Iss 4, Pp 1241-1252 (2022)
With quantum physics being a particularly difficult subject to teach because of its contextual distance from everyday life, the need for multiperspective teaching material arises. Quantum physics education aims at exploring these methods but often la
Externí odkaz:
https://doaj.org/article/d615aa2f7ed24661a3fd4349cdb29a8a
Autor:
Jane Bayani, Coralie Poncet, Cheryl Crozier, Anouk Neven, Tammy Piper, Carrie Cunningham, Monika Sobol, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Judith Fraser, Florentine Hilbers, Ingrid Hedenfalk, Larissa Korde, Barbro Linderholm, John Martens, Lavinia Middleton, Melissa Murray, Catherine Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Aleksandra Peric, Peggy Porter, Carolien Schröder, Isabel T. Rubio, Kathryn J. Ruddy, Christi van Asperen, Danielle Van Den Weyngaert, Carolien van Deurzen, Elise van Leeuwen-Stok, Joanna Vermeij, Eric Winer, Sharon H. Giordano, Fatima Cardoso, John M. S. Bartlett
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Male breast cancer (BCa) is a rare disease accounting for less than 1% of all breast cancers and 1% of all cancers in males. The clinical management is largely extrapolated from female BCa. Several multigene assays are increasingly used to g
Externí odkaz:
https://doaj.org/article/39b74ac02205476a9300ff36cbb33d6d
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The implementation of pharmacogenetic testing into clinical practice has been a slow process so far. Here, we review the implementation of pre-treatment testing of dihydropyrimidine dehydrogenase gene (DPYD) risk variants to prevent early-onset fluor
Externí odkaz:
https://doaj.org/article/6f384ba119b844bcbdf04ccc302131f9
Publikováno v:
Breast, Vol 62, Iss , Pp S58-S62 (2022)
Locally advanced breast cancer (LABC) is defined here as inoperable breast adenocarcinoma without distant metastases. Patients with LABC require a multidisciplinary approach. Given the risk of distant metastasis, staging exams are necessary. The inci
Externí odkaz:
https://doaj.org/article/569723842c3e456aa892dc887e58dc82
Autor:
Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, Christian Oehlschlegel, Olivia Pagani, Bernhard Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background The impact of HER2-targeted therapy alone followed by the addition of chemotherapy at disease progression (PD) versus upfront combination was investigated by the SAKK 22/99 trial. The aim of this exploratory analysis of the SAKK 2
Externí odkaz:
https://doaj.org/article/3a71b23e5f6e4fdeb49b83bd63c454c7
Autor:
Mariana Bustamante Eduardo, Vlad Popovici, Sara Imboden, Stefan Aebi, Nadja Ballabio, Hans Jörg Altermatt, Andreas Günthert, Rolf Jaggi
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background Breast cancer is a leading cause of cancer-related death in women worldwide. Despite extensive studies in all areas of basic, clinical and applied research, accurate prognosis remains elusive, thus leading to overtreatment of many
Externí odkaz:
https://doaj.org/article/06e512fcaf37410a8cb7a4f963a11cc2
Autor:
Seid Hamzic, Stefan Aebi, Markus Joerger, Michael Montemurro, Marc Ansari, Ursula Amstutz, Carlo Largiadèr
Publikováno v:
Swiss Medical Weekly, Vol 150, Iss 4748 (2020)
Fluoropyrimidines (FPs), mainly 5-fluorouracil (5-FU) and its oral prodrug capecitabine (Cap), remain the backbone of the treatment of many different solid tumors. Despite their broad use in clinical routine, 10–40% of patients experience severe, a
Externí odkaz:
https://doaj.org/article/0ef46732bff3495b8511d835fbe22eef
Autor:
Bernhard C. Pestalozzi, Christoph Tausch, Konstantin J. Dedes, Christoph Rochlitz, Stefan Zimmermann, Roger von Moos, Ralph Winterhalder, Thomas Ruhstaller, Andreas Mueller, Katharina Buser, Markus Borner, Urban Novak, Catrina Uhlmann Nussbaum, Bettina Seifert, Martin Bigler, Vincent Bize, Simona Berardi Vilei, Christoph Rageth, Stefan Aebi, The Swiss Group for Clinical Cancer Research (SAKK)
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background To evaluate the effect of Recurrence Score® results (RS; Oncotype DX® multigene assay ODX) on treatment recommendations by Swiss multidisciplinary tumor boards (TB). Methods SAKK 26/10 is a multicenter, prospective cohort study
Externí odkaz:
https://doaj.org/article/c9a8ea8a27db4f48921538bf341f9e66
Autor:
Gologan D; Department of Organic Chemistry, Doctoral School, Faculty of Chemical Engineering and Biotechnologies, Politehnica University, 011061 Bucharest, Romania.; Department of Research and Development, Themis Pathology SRL, 077190 Bucharest, Romania., Ștefan AE; Department of Research and Development, Themis Pathology SRL, 077190 Bucharest, Romania.; Department of Pathology, Doctoral School, Faculty of Veterinary Medicine, University of Agronomical Sciences and Veterinary Medicine, 011464 Bucharest, Romania., Militaru M; Department of Pathology, Doctoral School, Faculty of Veterinary Medicine, University of Agronomical Sciences and Veterinary Medicine, 011464 Bucharest, Romania., Sanda AC; Department of Research and Development, Themis Pathology SRL, 077190 Bucharest, Romania., Arjan S; Department of Research and Development, Themis Pathology SRL, 077190 Bucharest, Romania., Mușat S; Department of Research and Development, Themis Pathology SRL, 077190 Bucharest, Romania.; Department of Research and Development, LUMEA Inc., Lehi, UT 84043, USA., Leavitt MO; Department of Research and Development, LUMEA Inc., Lehi, UT 84043, USA., Stan R; Department of Organic Chemistry, Doctoral School, Faculty of Chemical Engineering and Biotechnologies, Politehnica University, 011061 Bucharest, Romania.
Publikováno v:
Veterinary sciences [Vet Sci] 2023 Apr 06; Vol. 10 (4). Date of Electronic Publication: 2023 Apr 06.